Mapping the schizophrenia quality of life scale to EQ-5D, HUI3 and SF-6D utility scores in patients with schizophrenia

References

• James SL, Abate D, Abate KH, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1789–1858. DOI:10.1016/S0140-6736(18)32279-7
   PubMed Web of Science ®Google Scholar
• Chong HY, Teoh SL, DB-C W, et al. Global economic burden of schizophrenia: a systematic review. Neuropsychiatr Dis Treat. 2016;12:357–373.
   PubMed Web of Science ®Google Scholar
• Picchioni MM, Murray RM. Schizophrenia. BMJ. 2007;335(7610):91–95.
   PubMed Web of Science ®Google Scholar
• Tandon R, Nasrallah HA, Schizophrenia KM. “Just the facts” 4. Clinical features and conceptualization. Schizophr Res. 2009;110(1–3):1–23.
   PubMed Web of Science ®Google Scholar
• Bobes J, Garcia-Portilla MP, Bascaran MT, et al. Quality of life in schizophrenic patients. Dialogues Clin Neurosci. 2007;9(2):215–226. DOI:10.31887/DCNS.2007.9.2/jbobes
   PubMedGoogle Scholar
• Eack SM, Newhill CE. Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis. Schizophr Bull. 2007;33(5):1225–1237.
   PubMed Web of Science ®Google Scholar
• de Pinho LMG, Pereira AMS, Chaves CMCB, et al. Quality of life scale and symptomatology of schizophrenic patients – a systematic review. Eur J Psych. 2018;32(1):1–10.
   Web of Science ®Google Scholar
• Karow A, Wittmann L, Schöttle D, et al. The assessment of quality of life in clinical practice in patients with schizophrenia. Dialogues Clin Neurosci. 2014;16(2):185–195. DOI:10.31887/DCNS.2014.16.2/akarow
   PubMed Web of Science ®Google Scholar
• Liberman RP, Kopelowicz A. Recovery from schizophrenia: a challenge for the 21st century. Int Rev Psychiatry. 2002;14(4):245–255.
   Web of Science ®Google Scholar
• Wiebe S, Guyatt G, Weaver B, et al. Comparative responsiveness of generic and specific quality-of-life instruments. J Clinical Epidemiol. 2003;56(1):52–60. DOI:10.1016/S0895-4356(02)00537-1
   PubMed Web of Science ®Google Scholar
• Rajagopalan K, Abetz L, Mertzanis P, et al. Comparing The discriminative validity of two generic and one disease-specific health-related quality of life measures in a sample of patients with dry eye. Value Health. 2005;8(2):168–174. DOI:10.1111/j.1524-4733.2005.03074.x
   PubMed Web of Science ®Google Scholar
• Zeng Y, Zhou Y, Lin J, et al. Generic and disease-specific quality of life and its predictors among Chinese inpatients with schizophrenia. Psychiatry Res. 2015;228(3):724–728.
   PubMed Web of Science ®Google Scholar
• Seow LSE, Tan THG, Abdin E, et al. Comparing disease-specific and generic quality of life measures in patients with schizophrenia. Psychiatry Res. 2019;273:387–393.
   PubMed Web of Science ®Google Scholar
• Brazier J, Connell J, Papaioannou D, et al. A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely used specific measures. Health Technol Assess. 2014;18(34):1–188. (Winchester, England). doi: 10.3310/hta18340.
   PubMed Web of Science ®Google Scholar
• Longworth L, Yang Y, Young T, et al. Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey. Health Technol Assess. 2014;18(9):1–224. (Winchester, England). DOI:10.3310/hta18090. .
   PubMed Web of Science ®Google Scholar
• Brazier JE, Yang Y, Tsuchiya A, et al. A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. Eur J Health Econ. 2010;11(2):215–225.
   PubMed Web of Science ®Google Scholar
• McKenna SP. Measuring quality of life in schizophrenia. Eur Psychiatry. 1997;12(3):267s–274s.
   PubMedGoogle Scholar
• Wilkinson G, Hesdon B, Wild D, et al. Self-report quality of life measure for people with schizophrenia: the SQLS. Br J Psychiatry. 2000;177:42–46.
   PubMed Web of Science ®Google Scholar
• Subramaniam M, Abdin E, Vaingankar JA, et al. Lifetime prevalence and correlates of schizophrenia and other psychotic disorders in Singapore. Front Psychiatry. 2021;12:650674.
   PubMed Web of Science ®Google Scholar
• Luo N, Seng B-K, Xie F, et al. Psychometric evaluation of the Schizophrenia Quality of Life Scale (SQLS) in English- and Chinese-speaking Asians in Singapore. Qual Life Res. 2008;17(1):115–122.
   PubMed Web of Science ®Google Scholar
• Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33(5):337–343.
   PubMed Web of Science ®Google Scholar
• EuroQol Group. EQ-5D-5L user guide: basic information on how to use the EQ-5D-5L instrument. 2014. Available from: http://www.euroqol.org/fileadmin/user_upload/Documenten/PDF/Folders_Flyers/UserGuide_EQ-5D-5L.pdf. [Accessed Nov 10, 2020].
   Google Scholar
• van Hout B, Janssen MF, Feng YS, et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health. 2012;15(5):708–715. DOI:10.1016/j.jval.2012.02.008
   PubMed Web of Science ®Google Scholar
• Subramaniam M, Abdin E, Poon LY, et al. EQ-5D as a measure of programme outcome: results from the Singapore early psychosis intervention programme. Psychiatry Res. 2014;215(1):46–51. DOI:10.1016/j.psychres.2013.10.002
   PubMed Web of Science ®Google Scholar
• Feeny D, Furlong W, Torrance GW, et al. Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Med care. 2002;40(2):113–128. DOI:10.1097/00005650-200202000-00006
   PubMed Web of Science ®Google Scholar
• Horsman J, Furlong W, Feeny D, et al. The Health Utilities Index (HUI®): concepts, measurement properties and applications. Health Qual Life Outcomes. 2003;1(1):54.
   PubMedGoogle Scholar
• Luo N, Seng BK, Thumboo J, et al. A study of the construct validity of the Health Utilities Index Mark 3 (HUI3) in patients with schizophrenia. Quality of life research: an international journal of quality of life aspects of treatment, care and rehabilitation. Qual Life Res. 2006;15(5):889–898. DOI:10.1007/s11136-005-5745-8
   PubMedGoogle Scholar
• Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21(2):271–292.
   PubMed Web of Science ®Google Scholar
• Abdin E, Chong SA, Seow E, et al. A comparison of the reliability and validity of SF-6D, EQ-5D and HUI3 utility measures in patients with schizophrenia and patients with depression in Singapore. Psychiatry Res. 2019;274:400–408.
   PubMed Web of Science ®Google Scholar
• Mukuria C, Rowen D, Harnan S, et al. An updated systematic review of studies mapping (or cross-walking) measures of health-related quality of life to generic preference-based measures to generate utility values. Appl Health Econ Health Pol. 2019;17(3):295–313. DOI:10.1007/s40258-019-00467-6
   PubMed Web of Science ®Google Scholar
• Pullenayegum EM, Tarride JE, Xie F, et al. Analysis of health utility data when some subjects attain the upper bound of 1: are Tobit and CLAD models appropriate? Value Health. 2010;13(4):487–494. DOI:10.1111/j.1524-4733.2010.00695.x
   PubMed Web of Science ®Google Scholar
• Basu A, Manca A. Regression estimators for generic health-related quality of life and quality-adjusted life years. Med Decis Making. 2012;32(1):56–69.
   PubMed Web of Science ®Google Scholar
• Austin PC. A comparison of methods for analyzing health-related quality-of-life measures. Value Health. 2002;5(4):329–337.
   PubMed Web of Science ®Google Scholar
• Gray LA, Alava MH. A command for fitting mixture regression models for bounded dependent variables using the beta distribution. Stata J. 2018;18(1):51–75.
   Web of Science ®Google Scholar
• Gray LA, Wailoo AJ, Hernandez Alava M. Mapping the FACT-B Instrument to EQ-5D-3L in patients with breast cancer using adjusted limited dependent variable mixture models versus response mapping. Value Health. 2018;21(12):1399–1405.
   PubMed Web of Science ®Google Scholar
• Gray LA, Hernández Alava M, Wailoo AJ. Development Of methods for the mapping of utilities using mixture models: mapping the AQLQ-S to the EQ-5D-5L and the HUI3 in patients with asthma. Value Health. 2018;21(6):748–757.
   PubMed Web of Science ®Google Scholar
• Kiadaliri A, Alava MH, Roos EM, et al. Mapping EQ-5D-3L from the Knee Injury and Osteoarthritis Outcome Score (KOOS). Quality of Life Research. 2020;29(1):265–274.
   PubMed Web of Science ®Google Scholar
• Yang F, Wong CKH, Luo N, et al. Mapping the kidney disease quality of life 36-item short form survey (KDQOL-36) to the EQ-5D-3L and the EQ-5D-5L in patients undergoing dialysis. Eur J Health Econ. 2019;20(8):1195–1206. DOI:10.1007/s10198-019-01088-5
   PubMed Web of Science ®Google Scholar
• Abdin E, Chong SA, Seow E, et al. Mapping the positive and negative syndrome scale scores to EQ-5D-5L and SF-6D utility scores in patients with schizophrenia. Quality of life research: an international journal of quality of life aspects of treatment, care and rehabilitation. 2019;28(1):177–186. DOI:10.1007/s11136-018-2037-7.
   Google Scholar
• Lenert LA, Rupnow MFT, Elnitsky C. Application of a disease-specific mapping function to estimate utility gains with effective treatment of schizophrenia. Health Qual Life Outcomes. 2005;3(1):57.
   PubMedGoogle Scholar
• Siani C, de Peretti C, Millier A, et al. Predictive models to estimate utility from clinical questionnaires in schizophrenia: findings from EuroSC. Quality of Life Research. 2016;25(4):925.
   PubMed Web of Science ®Google Scholar
• Cheung YB, Luo N, Ng R, et al. Mapping the functional assessment of cancer therapy-breast (FACT-B) to the 5-level EuroQoL Group’s 5-dimension questionnaire (EQ-5D-5L) utility index in a multi-ethnic Asian population. Health Qual Life Outcomes. 2014;12(1):180.
   PubMed Web of Science ®Google Scholar
• Dakin H. Review of studies mapping from quality of life or clinical measures to EQ-5D: an online database. Health Qual Life Outcomes. 2013;11(1):151.
   PubMedGoogle Scholar
• Wailoo AJ, Hernandez-Alava M, Manca A, et al. Mapping to Estimate Health-State Utility from Non–Preference-Based Outcome Measures: an ISPOR Good Practices for Outcomes Research Task Force Report. Value Health. 2017;20(1):18–27. DOI:10.1016/j.jval.2016.11.006
   PubMed Web of Science ®Google Scholar